Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Adaptimmune Therapeutics PLC | Director | Option to purchase Ordinary Shares | 711K | Jul 1, 2022 | Direct | ||
GW PHARMACEUTICALS PLC | Director | Ordinary Shares | 0 | May 5, 2021 | Direct | ||
GW PHARMACEUTICALS PLC | Director | Share Options | 0 | May 5, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ADAP | Adaptimmune Therapeutics PLC | Jul 1, 2022 | 1 | $0 | 4 | Jul 1, 2022 | Director |
ADAP | Adaptimmune Therapeutics PLC | Jul 1, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |
GWPH | GW PHARMACEUTICALS PLC | May 5, 2021 | 9 | $0 | 4 | May 7, 2021 | Director |